Entry |
|
Name |
|
Definition |
KSHV macrophage inflammatory protein 2
|
Pathway |
ko04061 | Viral protein interaction with cytokine and cytokine receptor |
ko05167 | Kaposi sarcoma-associated herpesvirus infection |
|
Brite |
KEGG Orthology (KO) [BR:ko00001]
09130 Environmental Information Processing
09133 Signaling molecules and interaction
04061 Viral protein interaction with cytokine and cytokine receptor
K21657 K4; KSHV macrophage inflammatory protein 2
09160 Human Diseases
09161 Cancer: overview
05203 Viral carcinogenesis
K21657 K4; KSHV macrophage inflammatory protein 2
09172 Infectious disease: viral
05167 Kaposi sarcoma-associated herpesvirus infection
K21657 K4; KSHV macrophage inflammatory protein 2
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
03200 Viral proteins
K21657 K4; KSHV macrophage inflammatory protein 2
Viral proteins [BR:ko03200]
dsDNA viruses
Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8)
K21657 K4; KSHV macrophage inflammatory protein 2
|
Genes |
|
Reference |
|
Authors |
Luttichau HR, Johnsen AH, Jurlander J, Rosenkilde MM, Schwartz TW |
Title |
Kaposi sarcoma-associated herpes virus targets the lymphotactin receptor with both a broad spectrum antagonist vCCL2 and a highly selective and potent agonist vCCL3. |
Journal |
|
Sequence |
|
LinkDB |
|